Modulight Biotherapeutics
Modulight Biotherapeutics is developing a first-in-class optogenetic precision neuromodulation therapy for neurological disorders, using a patented GPCR-opsin, a light-sensitive protein.
Modulight Biotherapeutics is developing a first-in-class optogenetic precision neuromodulation therapy for neurological disorders, using a patented GPCR-opsin, a light-sensitive protein.